ClinicalTrials.Veeva

Menu

Exploring Biological Linkage Between Circadian Disruption and Cancer Progression

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Breast Neoplasms

Study type

Observational

Funder types

Other

Identifiers

NCT02011815
BreastCA_circa_mech

Details and patient eligibility

About

The purpose of this study is to explore the possible association between the circadian disruption and cancer progression.

Full description

The biological markers that are assumed to bridge this association are measured and analyzed.

Enrollment

236 estimated patients

Sex

Female

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age: 18-70
  • Breast cancer patients who are getting chemotherapy for the first time in life
  • Patients are either having stage 4 cancer or starting neoadjuvant chemotherapy.
  • Patient have signed on the informed consent, and well understood the objective and procedure of this study

Exclusion criteria

  • Patients already have received chemotherapy
  • Patient had another cancer (except thyroid cancer) within 5 years
  • Patient with severe medical condition
  • Patient had taken psychiatric medication more than 1 month in life
  • Patient worked the night shift for more than 1 month in 6 months

Trial design

236 participants in 1 patient group

Breast cancer
Description:
Diagnosed breast cancer patients who are getting chemotherapy for the first time.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems